Column Group’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-161,049
| Closed | -$2.42M | – | 7 |
|
|
2023
Q3 | $2.42M | Sell |
161,049
-11,324
| -7% | -$170K | 1.6% | 7 |
|
|
2023
Q2 | $3.58M | Hold |
172,373
| – | – | 1.39% | 7 |
|
|
2023
Q1 | $1.52M | Hold |
172,373
| – | – | 0.55% | 7 |
|
|
2022
Q4 | $1.84M | Hold |
172,373
| – | – | 0.61% | 7 |
|
|
2022
Q3 | $2.47M | Hold |
172,373
| – | – | 0.55% | 7 |
|
|
2022
Q2 | $6.12M | Hold |
172,373
| – | – | 1.3% | 7 |
|
|
2022
Q1 | $17.3M | Hold |
172,373
| – | – | 3.2% | 7 |
|
|
2021
Q4 | $35.7M | Hold |
172,373
| – | – | 4.85% | 7 |
|
|
2021
Q3 | $60.5M | Buy |
+172,373
| New | +$60.5M | 6.89% | 6 |
|